CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 3 Insider Initial Statement of Ownership
- CT ORDER Other Confidential Order
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation · Shareholder rights changed · Executive or director change · Regulation FD disclosure
- F-6 POS Other F-6 POS
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- SC 13D Stake Beneficial Ownership Report
Page 61 of 64 · 1,278 filings